Free Trial

Amplifon (AMFPF) Expected to Announce Quarterly Earnings on Tuesday

Amplifon logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Amplifon is expected to report quarterly results on Tuesday, May 5, with analysts forecasting EPS of $0.1502 and revenue of $677.94 million.
  • The stock opened at $10.09 and trades below its 50- and 200-day SMAs ($11.94 and $14.88), with a one-year range of $9.46–$23.85; the company has a market cap of $2.22 billion and a P/E of 18.01.
  • Jefferies recently downgraded Amplifon from "strong-buy" to "hold," though the consensus remains a Moderate Buy (two Buys, one Hold).
  • MarketBeat previews the top five stocks to own by May 1st.

Amplifon (OTCMKTS:AMFPF - Get Free Report) is expected to be announcing its resultson Tuesday, May 5th. Analysts expect the company to announce earnings of $0.1502 per share and revenue of $677.9420 million for the quarter.

Amplifon Price Performance

AMFPF opened at $10.09 on Tuesday. The stock's 50 day simple moving average is $11.94 and its 200 day simple moving average is $14.88. The company has a debt-to-equity ratio of 1.14, a current ratio of 0.62 and a quick ratio of 0.54. Amplifon has a 1 year low of $9.46 and a 1 year high of $23.85. The firm has a market cap of $2.22 billion, a price-to-earnings ratio of 18.01 and a beta of 0.63.

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group lowered Amplifon from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, March 18th. Two investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. According to data from MarketBeat.com, Amplifon has an average rating of "Moderate Buy".

View Our Latest Report on Amplifon

Amplifon Company Profile

(Get Free Report)

Amplifon is a global leader in hearing care, specializing in the retail and distribution of hearing aids, accessories and related services. The company offers a full suite of solutions including diagnostic hearing assessments, personalized hearing aid fittings, follow-up care, tinnitus management and hearing protection. Through its network of branded stores and partner outlets, Amplifon serves individuals across the full spectrum of hearing needs, from prevention and early detection to long-term aftercare.

Founded in Milan in 1950 by Algernon Charles Holland, Amplifon has grown from a single audiology centre into a multinational organization.

See Also

Earnings History for Amplifon (OTCMKTS:AMFPF)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Amplifon Right Now?

Before you consider Amplifon, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amplifon wasn't on the list.

While Amplifon currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines